Synapse formation and regression in the cortex during adolescence and in schizophrenia

Medical Journal of Australia

Volumn 190, Issue 4 SUPPL., 2009, Pages

  Bennett, Maxwell R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DYSBINDIN; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR; NEUREXIN; NEUROLIGIN;

ADOLESCENT DEVELOPMENT; ARTICLE; HUMAN; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NONHUMAN; PREFRONTAL CORTEX; SCHIZOPHRENIA; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS;

EID: 61849159171     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02368.x     Document Type: Article

References (22)

1. Huttenlocher PR. Synaptic density in human frontal cortex - development changes and effects of aging. Brain Res 1979; 163: 195-205.
2. Glantz LA, Lewis DA. Decreased clendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57: 65-73.
3. Glantz LA, Gilmore JH, Hamer RM, et al. Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood. Neuroscience 2007; 149: 582-591.
4. McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiat 2000; 57: 637-648.
5. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiat Res 1982; 17: 319-334.
6. Pantelis C, Velakoulis D, Wood SJ, et al. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int Rev Psychiatry 2007; 19: 371-381.
7. Hesser BA, Henschel O, Witzemann V Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSK. Mot Cell Neurosci 2006; 31: 470-480.
8. Misgeld T, Kummer TT, Lichtman JW, Sanes JR. Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter. Proc Natl Acad Sci U S A 2005; 102: 11088-11093.
9. Kim N, Burden SJ. MuSK controls where axons grow and form synapses. Nat Neurosci 2008; 11: 19-27.
10. Grabham PW, Seale GE, Bennecib M, et al. Cytoplasmic dynein and LIS1 are required for microtubule advance during growth cone remodeling and fast axonal outgrowth. J Neurosci 2007; 27: 5823-5834.
11. Mackie S, Millar JK, Porteous DJ. Role of DISC1 in neural development and schizophrenia. Curr Opin Neurobiol 2007; 17: 95-102.
12. Bennett MR. Dual constraints on synapse formation and regression in schizophrenia: neuregulin, neuroligin, clysbindin, DISC1, MuSK and agrin. Aust N Z J Psychiatry 2008; 42: 662-677.
13. Ksiazek I, Burkhardt C, Lin S, et al. Synapse loss in cortex of agrin-deficient mice after genetic rescue of perinatal death. J Neurosci 2007; 27: 7183-7195.
14. Numakawa T, Yagasaki Y, Ishimoto T, et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 2004; 13: 2699-2708.
15. Lin B, Woo RS, Mei L, Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 2007; 54: 583-597.
16. Ikuta J, Maturana A, Fujita T, et al. Fasciculation and elongation protein zeta-1 (FEZ1) participates in the polarization of hippocampal neuron by controlling the mitochondrial motility. Biochem Biophys Res Commun 2007; 353: 127-132.
17. Dudanova I, Taabuchi K, Rohlmann A, et al. Deletion of alpha-neurexins does not cause a major impairment of axonal pathfinding or synapse formation. J Comp Neurol 2007; 502: 261-274.
18. Weickert CS, Straub RE, McClintock BW, et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 2004; 61: 544-555.
19. Chong VZ, Thompson M, Beltaifa S, et al. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 2008; 100: 270-280.
20. Brandon NJ, Handford EJ, Schurov I, et al. Disrupted In Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci 2004; 25: 42-55.
21. Mitelman SA, Brickman AM, Shihabuddin L, et al. A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage 2007; 37: 449-462.
22. McGorry PD, Purcell R, Hickie IB, et al. Clinical staging: a heuristic model for psychiatry and youth mental health. Med J Aust 2007; 187 (7 Suppl): S40-S42.